搜索临床试验以:Part 3, Period 1
总计2680个结果
-
Sun Pharma Advanced Research Company Limited终止
-
iN Therapeutics Co., Ltd.招聘中
-
Chiesi Farmaceutici S.p.A.终止
-
Ichnos Sciences SAGlenmark Pharmaceuticals S.A.完全的
-
LG Life Sciences完全的
-
Janssen Research & Development, LLCPharmacyclics LLC.完全的
-
Janssen Research & Development, LLC完全的
-
Bilthoven BiologicalsSerum Institute of India Pvt. Ltd.完全的
-
Kanyos Bio, Inc., a wholly-owned subsidiary of...Pfizer招聘中
-
University of MiamiUniversity of Miami Sylvester Comprehensive Cancer Center撤销
-
Abramson Cancer Center at Penn Medicine主动,不招人
-
Ziqiang Li主动,不招人60名患者的完整准确的统计数据 | 准确分析60名供体和受体的CYP3A5*3基因型 | 准确记录 60 名患者术后他克莫司浓度 | 根据《急性肾损伤诊断及分级标准》统计60例患者术后急性肾损伤的病例及分级 | 科学严谨的数据统计分析中国
-
Czech Lymphoma Study GroupHoffmann-La Roche; Ministry of Health, Czech Republic完全的
-
Emory UniversityNational Cancer Institute (NCI); Novartis; Secura Bio, Inc.招聘中
-
Boryung Pharmaceutical Co., Ltd完全的